Wu Chunxiao, Pan Jinlan, Qiu Huiying, Xue Yongquan, Chen Suning, Wu Yafang, zhang Jun, Bai Shuxiao, Wang Yong, Shen Juan, Gong Yanlei
Key Laboratory of Thrombosis and Hemostasis, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, 188 shizi street, Suzhou, 215006, People's Republic of China.
Int J Hematol. 2015 Nov;102(5):617-25. doi: 10.1007/s12185-015-1872-3. Epub 2015 Oct 6.
Deletion of the long arm of chromosome 20 is a common abnormality underlying hematological malignancy. We analyzed 21 patients with hematologic diseases confirmed to carry the del(20q) by conventional cytogenetics and fluorescence in situ hybridization using microarray comparative genomic hybridization (aCGH). Seventeen patients were positive for del(20q), but this deletion was not detected in four patients. All deletions detected were interstitial of which continuous deletions were seen in 12 patients and discrete deletions in five. Three commonly deleted regions (CDRs) and two commonly retained regions (CRRs) were defined: CDR1 spanning 3.05Mb (34560497-37608229) within 20q11.23, CDR2 spanning 1.76Mb (37851501-39615698) within 20q12, CDR3 spanning 116Kb (48120412-48236791) within 20q13.13, CRR1 spanning 1.1Mb (29374726-30428250) within 20q11.21, and CRR2 spanning 2.5Mb (60484668-62963548) within 20q13.33. Duplications of retained regions (20q11.21) were found in five cases with similar erythroid hyperplasia (2 M6, 3 MDS). Moreover, duplication of 20p13-p11.21 was also found in two cases with M6. Using the CDRs and CRRs, we identified the candidate genes we searched for using the UCSC Genome Browser. Our data suggest that aCGH analysis is useful for more precisely defining breakpoints on 20q. Further work is required to identify candidate pathogenic genes within these CDRs and CRRs.
20号染色体长臂缺失是血液系统恶性肿瘤常见的潜在异常。我们使用微阵列比较基因组杂交技术(aCGH),通过传统细胞遗传学和荧光原位杂交分析了21例经确诊携带20号染色体长臂缺失(del(20q))的血液病患者。17例患者del(20q)呈阳性,但4例患者未检测到该缺失。所有检测到的缺失均为中间缺失,其中12例患者为连续性缺失,5例为离散性缺失。定义了3个常见缺失区域(CDR)和2个常见保留区域(CRR):CDR1位于20q11.23,跨度为3.05Mb(34560497 - 37608229);CDR2位于20q12,跨度为1.76Mb(37851501 - 39615698);CDR3位于20q13.13,跨度为116Kb(48120412 - 48236791);CRR1位于20q11.21,跨度为1.1Mb(29374726 - 30428250);CRR2位于20q13.33,跨度为2.5Mb(60484668 - 62963548)。在5例具有相似红系增生的病例(2例M6,3例骨髓增生异常综合征)中发现了保留区域(20q11.21)的重复。此外,在2例M6病例中还发现了20p13 - p11.21的重复。利用这些CDR和CRR,我们通过UCSC基因组浏览器确定了我们搜索的候选基因。我们的数据表明,aCGH分析有助于更精确地确定20q上的断点。需要进一步开展工作以确定这些CDR和CRR内的候选致病基因。